Maxime Verhoeven

15 General introduction 15. Jacobs, J. W. G., ten Cate, D. F. & van Laar, J. M. Monitoring of rheumatoid arthritis disease activity in individual patients: still a hurdle when implementing the treat-to-target principle in daily clinical practice. Rheumatology 54 , 959–961 (2015). 16. Pincus, T. & Segurado, O. G. Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count. Ann. Rheum. Dis. 65 , 820–822 (2006). 17. Smolen, J. S. & Aletaha, D. Scores for all seasons: SDAI and CDAI. Clin. Exp. Rheumatol. 32 , S75–S79 (2014). 18. van der Heijde, D. & Landewé, R. Should radiographic progression still be used as outcome in RA ? Clin. Immunol. 186 , 79–81 (2018). 19. Besselink, N. J. et al. Optical spectral transmission to assess inflammation in hand and wrist joints of rheumatoid arthritis patients. Rheumatology 57 , 865–872 (2018). 20. Kalkan, A., Hallert, E., Bernfort, L., Husberg, M. & Carlsson, P. Costs of rheumatoid arthritis during the period 1990-2010: a register-based cost-of-illness study in Sweden. Rheumatology 53 , 153–160 (2014). 21. Hsieh, P. H. et al. Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era. Ann. Rheum. Dis. 79 , S771–S777 (2020). 22. Burmester, G. R. & Pope, J. E. Novel treatment strategies in rheumatoid arthritis. Lancet 389 , 2338–2348 (2017). 23. Kerschbaumer, A. et al. Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. Ann. Rheum. Dis. 79 , S744–S759 (2020). 24. Markusse, I. M. et al. Evaluating adherence to a treat-to-target protocol in recent-onset rheumatoid arthritis: reasons for compliance and hesitation. Arthritis Care Res. 68 , 446–453 (2016). 1